About us

About Phenotypeca®

Phenotypeca is a yeast Biofoundry business.

We have the world’s largest collection of yeast strains engineered for industrial recombinant protein production, comprising up to a billion genetically distinct strains.

We will create and own yeast synthetic biology solutions to make any recombinant protein, but initially vaccines, diagnostics and therapeutic proteins.

Our mission is to make life-saving medicines more affordable and accessible to all of those who need them.

  1. Phenotypeca Limited Incorporated

    Find out more
  2. Ed Louis joins Phenotypeca as Chief Scientist

    Find out more
  3. Patrick Florent from the world of vaccines and patent attorney Anton Hutter join the Phenotypeca Advisory Board

    Find out more
  4. Phenotypeca wins £373,000 Innovate UK Smart Grants for the development of second-generation S. cerevisiae hosts for enhanced protein yield and quality

    Find out more
  5. Phenotypeca wins a voucher for the exploration of how the genetic diversity of Saccharomyces cerevisiae may be harnessed for the production of VLPs with The Future Vaccine Manufacturing Research Hub (Vax-Hub).

    Find out more
  6. Phenotypeca win IUK grant for the ‘rapid response to COVID-19’ competition

    Find out more

Get in Touch

If you have any questions, or would like to find out more about our unique processes, please get in touch.